Cephalexin For recalls

The FDA has published 12 recalls involving Cephalexin For since 2019. The latest was reported on 18 Jun 2025. Most were for potency & assay. Ascend Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls12since 2019

Last 12 months0reported

Class I00% of total

Ongoing2latest 18 Jun 2025

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 2Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 11 92%Class III 1 8%

Why cephalexin for is recalled

Companies

By year

2025217%
2021542%
2020325%
2019217%

Ongoing cephalexin for recalls

2 active

Reported	Class	Recall	Company	Reason	Where
18 Jun 2025Drug	CLASS II	Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide
18 Jun 2025Drug	CLASS II	Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide

All cephalexin for recalls, newest first

12 total

Reported	Class	Recall	Company	Reason	Where
18 Jun 2025Drug	CLASS II	Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide
18 Jun 2025Drug	CLASS II	Cephalexin for Oral Suspension, USP, 125 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide
24 Feb 2021Drug	CLASS II	Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide
24 Feb 2021Drug	CLASS II	Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide
13 Jan 2021Drug	CLASS II	Cephalexin for Oral Suspension, USP, 125 mg recalled	Ascend Laboratories	Potency & Assay	Nationwide
6 Jan 2021Drug	CLASS II	Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide
6 Jan 2021Drug	CLASS II	Cephalexin for Oral Suspension, USP 250 mg per (when mixed) recalled	Ascend Laboratories	Potency & Assay	Nationwide
16 Sep 2020Drug	CLASS II	Cephalexin for Oral Suspension, USP 250 mg recalled	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
16 Sep 2020Drug	CLASS II	Cephalexin for Oral Suspension, USP 125 mg recalled	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	Nationwide
16 Sep 2020Drug	CLASS II	Cephalexin for Oral Suspension, USP 250 mg recalled	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	Nationwide
13 Nov 2019Drug	CLASS III	Cephalexin for Oral Suspension USP, 250 mg recalled	Lupin Pharmaceuticals	Other	Nationwide
23 Jan 2019Drug	CLASS II	Cephalexin for Oral Suspension USP, 250mg/ (when mixed) recalled	Lupin Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide

Should you stop taking Cephalexin For?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.